INVESTOR INFORMATION
BioShield is finalizing the first phase of implementation in the first half of 2024. We are currently raising USD 17 million Series A to fund the second phase of implementation. The Series A will be raised globally and will be used to prepare the company to begin construction. Interested parties please contact us.
Click below to log in to the investor information page, or contact us to request access.
